Feature | November 22, 2010

Trends in Radiation Oncology From ASTRO 2010

Radiation oncology as a profession is in a period of retrenchment due to the economic crisis. There is also a growing demand from payors to show value for these treatments, said ASTRO President Anthony Zeitman, M.D. He says the technologies used need to undergo rigorous clinical testing to show what works best and what is most cost-effective. Part of ASTRO's push is for a national registry to help advance this data collection.

Related Content

New partnership makes outstanding radiation protection solutions available to healthcare professionals
News | Radiation Dose Management
BIOTRONIK and Texray Establish Collaboration to Distribute Texray’s Innovative Radiation Protection Products

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Radiation Therapy
Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
LUMISIGHT and Lumicell Direct Visualization System (DVS) offer 84% diagnostic accuracy in detecting residual cancer, in real-time, that may have been otherwise missed during lumpectomy surgery, while sparing some from second surgeries
News | FDA
Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients on whether to proceed with lung cancer screening is fraught with confusion and lack of evidence-based information, and may actually be undermining the purpose for which it was created
News | Lung Imaging
Mount Sinai Study Calls for Major Changes in the Way People With Comorbidities Are Selected by Physicians for Lung Cancer Screening

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
Collaboration includes robust education and training to support radiologists and imaging specialists
News | Mammography
Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
The latest MyBreastAI Suite supports clinicians in accelerating breast cancer detection, while the company’s Pristina Bright solution helps healthcare providers start a new contrast program
News | Mammography
GE HealthCare to feature Mobile Mammography Screening Truck along with Latest AI Platform as part of SBI2024 Breast Cancer Imaging Showcase

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
Under the terms of the agreement, RTsafe's dosimetry phantom based on true-to-life human anatomy will be seamlessly integrated into ZAP Surgical's existing and future global installations.
News | Radiation Therapy
RTsafe and ZAP Surgical Forge Strategic Partnership to Promote the Latest Advances in Cranial Radiosurgery

April 12, 2024 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery, and ...

Time April 12, 2024
arrow
Sponsored collaboration will focus on evaluating the ability of PreciseBreast to accurately predict breast cancer recurrence for those patients with TNBC
News | Artificial Intelligence
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence

April 9, 2024 —PreciseDx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for ...

Time April 09, 2024
arrow
New research published in Clinical Cancer Research shows significant improvement in distant recurrence-free survival with combined durvalumab and tremelimumab treatment, supported by Lunit SCOPE IO’s analysis of tumor microenvironment
News | Artificial Intelligence
Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

April 8, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time April 08, 2024
arrow
Here is a look at the most-read content during the month of March on itnonline.com
Feature | Radiology Business | By Melinda Taschetta-Millane
Top 10: Must-reads from the Month of March

Here is a snapshot of the Top 10 most-read content from ITN's viewers during the month of March: 1. Philips Teams with ...

Time April 04, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now